Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT Apr 13, 2022
Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and… Apr 13, 2022
Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research Apr 12, 2022
